After the NLRP3 inflammasome is activated, it causes an inflammatory cascade reaction, leading to the release of pro-inflammatory factors such as IL-1β, IL-18, IL-22, TNF-α, and the activation of inflammation-tumor signaling pathways such as NF-κB. This evidence concerns the gene IL22 and neoplasm.